Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Electronics (005930) – Consolidated Provisional Operating Performance (Fair Disclosure) / 2026-04-30 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Advance Notice of Earnings Release / 2025-01-10 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2026-01-29 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Outlook on Sales Performance, Etc. (Fair Disclosure) / 2025-01-03 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Provisional Consolidated Financial Results / 2025-11-03 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Serious Industrial Accident / 2026-03-19 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Modification of Listing (Retirement of Shares) / 2026-02-13 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-06-17 Disclosures

[Disclosure] Celltrion (068270) – Decision on Cash Dividend / 2024-12-13

Posted on December 13, 2024August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion decided to distribute a year-end cash dividend of KRW 750 per common share (totaling KRW 153,773,154,750) with a record date of December 31, 2024.

📊 Key Disclosure Content & Financial Highlights

  1. Overview
  • Company: Celltrion, Inc. (Stock Code: 068270)
  • Disclosure Type: Decision on Cash Dividend (Year-End Dividend)
  • Board Resolution Date: 2024-12-13
  • Record Date: 2024-12-31
  1. Cash Dividend Details
  • Dividend Type: Cash Dividend
  • Dividend per Share: KRW 750 per common share
  • Total Dividend Amount: KRW 153,773,154,750 (approx. KRW 153.8B)
  • Differential Dividend Status: Not Applicable
  • Dividend Yield: Undetermined (to be re-disclosed upon finalization after the record date)
  1. Key Details & Investment Risks
  • The cash dividend proposal will be submitted to the 34th Annual General Meeting of Shareholders and is subject to change depending on external audit results and shareholder voting outcomes.
  • Total dividend amount was calculated based on 205,030,873 shares, excluding 12,047,681 treasury shares (including planned acquisition volume) from the total issued shares of 217,078,554.
  • Treasury share counts may vary depending on appraisal rights exercises and will be re-disclosed if changes occur upon reviewing the shareholder register on the record date (2024-12-31).
  • Expected payment date will be within 1 month following the Annual General Meeting resolution pursuant to Article 464-2 of the Commercial Code.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Shareholder Meeting Approval and Cash Dividend Payment

This disclosure serves as official notification regarding the board resolution to distribute a cash dividend of KRW 750 per common share for FY2024. Tracking whether the cash dividend proposal receives final approval at the 34th Annual General Meeting of Shareholders is important for confirming the execution of dividend distribution. Relevant updates can be confirmed through subsequent shareholder meeting convocation notices, meeting outcome disclosures, and periodic filings.

📢 Disclaimer & Source Notice

Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Decision on Stock Dividend / 2024-12-13
Next Post: [Disclosure] Celltrion (068270) – Decision on Closure of Shareholders’ Register (Record Date) for Cash/In-Kind Dividend / 2024-12-13

Related Posts

  • [Disclosure] Hana Micron (067310) – (Correction) Setting of Closure Period of Shareholders’ Register or Record Date / 2024-12-16 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Occurrence of Serious Industrial Accident / 2026-03-16 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2026-04-22 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2024-10-29 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Announcement / 2025-01-08 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Submission of Audit Report / 2026-03-23 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Major Management Matters Related to Investment Decisions / 2024-12-19 Disclosures
  • [Disclosure] PSK Holdings (031980) – Setting of Record Date or Period for Closure of Shareholder Register / 2025-12-16 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI & ADAS Mix · Margin Expansion · Valuation Re-rating / 2025-01-31 RESEARCH
  • [Disclosure] SK Square (402340) – Audit Report Submission / 2025-03-11 Semiconductors
  • [Disclosure] PSK Holdings (031980) – Investor Relations (IR) Host / 2026-05-11 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2024-05-29 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Conclusion of Trust Contract for Treasury Stock Acquisition / 2024-09-24 Semiconductors
  • [Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Avtozma (CT-P47, Actemra/RoActemra Biosimilar) / 2025-02-24 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme